Revision of measures to combat intractable diseases in Japan: Three pillars will play an even greater role in the future

Intractable and Rare Diseases Research

Volumn 2, Issue 1, 2013, Pages 33-34

  Song, Peipei ^a   Kokudo, Norihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

orphan drugs; Rare diseases

Indexed keywords

EID: 84975196029     PISSN: 21863644     EISSN: 2186361x     Source Type: Journal    
DOI: 10.5582/irdr.2013.v2.1.33     Document Type: Article

References (4)

1. The Japanese Ministry of Health, Labor, and Welfare. Revision of Measures to Combat Intractable Diseases. http://www.mhlw.go.jp/stf/houdou/2r9852000002udoe. html (accessed February 1, 2013).
2. Song PP, Gao JJ, Inagaki Y, Kokudo N, Tang W. Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives. Intractable Rare Dis Res. 2012; 1:3-9.
3. Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Intractable and rare diseases research in Asia. Biosci Trends. 2012; 6:48-51.
4. Song PP, Gao JJ, Kokudo N, Tang W. New opportunity for orphan drug development in Japan: Early exploratory clinical trial bases promote drug translation from basic studies to clinical application. Intractable Rare Dis Res. 2012; 1:95-97.